Informacje dodatkowe
| Use in sports | None |
|---|---|
| Formula | C19H22BrNO4S2 |
| Side effects | Dry mouth, cough, sinusitis, upper respiratory tract infection, constipation, urinary retention |
| Effects | Promotes bronchodilation, reduces bronchospasm |
| Dosage (sports) | Not applicable |
| Dosage (medical) | 18 micrograms once daily via inhalation |
| Half-life | 5 to 6 days |
| Main action | Inhibits acetylcholine's action on bronchial smooth muscle leading to bronchodilation |
| Substance class | Anticholinergic bronchodilator |
| Chemical name | Tiotropium bromide |
| Storage conditions | Store at room temperature away from moisture and heat |
| Trade name | Spiriva |
| Blood pressure | Little or no effect on blood pressure |
| Also known as | Tiotropium |
| Lab Test | Not typically affected by standard lab tests |
| Hepatotoxicity | No known hepatotoxic effects |
| Water Retention | No |
| Raw Material | Tiotropium Bromide |
| Manufacturer | Boehringer Ingelheim |
| Packing | 30 caps (18 mg) |
Opinie
Na razie nie ma opinii o produkcie.